14:00-14:30 PM |
Climate Neutral Materials for Next-generation Drug Delivery Devices
Until now, drug delivery devices would require tedious sorting with a variety of materials used in various components. Now, with an all-polycarbonate device, minimal sorting would be required. At the end of life, the unit can be quickly and easily disassembled, then sorted into contaminated and non-contaminated components for easier disposal or recycling. This helps reduce medical waste while reducing the carbon footprint of the overall drug delivery device.
Covestro’s new line of Climate Neutral healthcare-grade polycarbonates, Makrolon RE, bring new levels of performance and sustainability to the medical device market with an all-polycarbonate device.
Join us to learn more about Covestro´s innovative design for sustainability efforts and how you can benefit from these developments.
Bernd Garska, Technical Marketing Manager Healthcare EMEA, Covestro AG
|
14:30-15:00 PM |
Sustainability in Drug Delivery: A Green Future without compromising Safety and Efficacy
Every day 14,000 tons of medical waste are generated at healthcare facilities across the U.S. alone. Up to 20-25% of this waste can be attributed to plastic packaging and plastic products. Increasingly there are movements towards sustainable packaging solutions in the consumer sector. The businesses that minimise waste and maximise resource utilisation through a combination of reuse, redistribution, and recycling will lead the future economy. But can such actions translate to the medical industry without compromising the safety, efficacy, and sterility of life-saving therapeutics?. This session will outline:
- Efficiently Designed Drug Delivery Devices
- Smart Technology for Labels and Instructions
- Modular and Sustainable Packaging Solutions
- Smart Supply Chain Technologies
Mayur Patel, Digital Health Expert, PA Consulting
|
15:30-16:00 PM
|
Strategies & Challenges for Delivering more Sustainable and Recyclable Packaging to the Medical Community
As consumers awareness and demand continues to grow, switching to sustainable packaging materials and practices can help companies stay relevant and profitable.
The desire to reduce waste, technological advancements and the changes within the regulatory standards will drive the adoption of sustainable materials and practices in the pharmaceutical packaging industry.
Isabelle Jenny, Sustainability Manager, Amcor in collaboration with Healthcare Plastics Recycling Council (HPRC)
|
16:00-16:30 PM |
Sustainability through Circular Initiatives
By 2030 Merck has pledged to lower its indirect emissions along the entire value chain (Scope 3) by 52% per euro value added.
To achieve this goal, Healthcare is continuously engaging with its suppliers to find opportunities to reduce their emissions, through (for instance) a more circular economy.
This presentation will focus on how Healthcare is currently improving packaging reuse in its supply chain by working in close partnership with its suppliers.
(One example of packaging reuse in a GMP environment will be showcased during the conference).
Corinne Ondo, Head of Sourcing Production Materials Biotech & Healthcare Innovation, Merck
|
16:30 - 17:00 PM |
Top Strategies for Environmental Sustainability with Examples
Environmental sustainability is the defining challenge of our time. Whereas most global emergencies, such as the financial crisis or Covid, are likely to be measured in years, it will take decades of substantial change to achieve sustainability.
Drug delivery devices have, for years, prioritised other considerations such as efficacy, safety and cost, over environmental sustainability, almost to its exclusion entirely. But there are increasing signs that societies around the world will no longer tolerate insufficient action on our part. We must rise to the task of environmental sustainability, but how?
This session will give every viewer helpful insight for understanding and navigating the future of drug delivery device development, covering some high-level strategies, with examples where possible, including:
- Device reuse options and limitations
- Device concept selection
- Recycling strategies
- Material selection
- Supply and distribution networks, for example, air miles
- Reduction in chemical use, for example, sterilisation and propellants
- Lifecycle analysis metrics and tools
Tom Oakley, Director of Drug Delivery Device Development, Springboard
|